GapMind for catabolism of small carbon sources

 

Alignments for a candidate for glcV in Chromobacterium vaccinii MWU205

Align monosaccharide-transporting ATPase (EC 3.6.3.17) (characterized)
to candidate WP_046157452.1 VL52_RS13280 ABC transporter ATP-binding protein

Query= BRENDA::Q97UY8
         (353 letters)



>NCBI__GCF_000971335.1:WP_046157452.1
          Length = 361

 Score =  201 bits (512), Expect = 2e-56
 Identities = 119/321 (37%), Positives = 190/321 (59%), Gaps = 23/321 (7%)

Query: 1   MVRIIVKNVSKVFKKGKVVALDNVNINIENGERFGILGPSGAGKTTFMRIIAGLDVPSTG 60
           M  + +KNV K F  G   A+++V++++E GE F +LGPSG GKTT +R++AG + P  G
Sbjct: 1   MALLEIKNVVKRF--GDYTAVNDVSLSVEAGEFFTLLGPSGCGKTTLLRMLAGFEQPDAG 58

Query: 61  ELYFDDRLVASNGKLIVPPEDRKIGMVFQTWALYPNLTAFENIAFPLTNMKMSKEEIRKR 120
           ++  D + ++      V PE R +  VFQ++AL+P++T  ENIAFPL   K  K +I  +
Sbjct: 59  QILLDGQDMSQ-----VAPEKRPVHTVFQSYALFPHMTVRENIAFPLKMAKWDKRKIAAQ 113

Query: 121 VEEVAKILDIHHVLNHFPRELSGGQQQRVALARALVKDPSLLLLDEPFSNLDARMRDSAR 180
           V+E+ + + +    + +P E+SGGQ+QRVA+ARALV  P LLLLDEP S LDA++R+  +
Sbjct: 114 VDELLEDVRLTQFGDRYPHEMSGGQRQRVAIARALVDRPRLLLLDEPLSALDAKLREEMQ 173

Query: 181 ALVKEVQSRLGVTLLVVSHDPADIFAIADRVGVLVKGKLVQVGKPEDLYDNPVSIQVASL 240
             +  +Q  +G+T + V+HD  +  A++ R+ V+  GK+ Q+  PE LY  P +  VA  
Sbjct: 174 IELINLQKEVGITFVYVTHDQGEALALSHRIAVMSHGKVEQLDAPEKLYSYPKNRFVADF 233

Query: 241 IGEINELEG--KVTNEGVVIGSLR---------FPVSVSSDRAIIGIRPEDVKLSKDV-- 287
           +G+ N LEG  K  +   +  +L+          P      +  + +RPE VKL K++  
Sbjct: 234 LGQCNVLEGTVKALHGDAMTVALKGCGDVKCQAVPGVKEGQQGWLALRPEKVKLDKELPE 293

Query: 288 IKDDSWILVGKGKVKVIGYQG 308
           + D+++    KG+V    Y G
Sbjct: 294 LPDEAYF---KGRVHDCLYLG 311


Lambda     K      H
   0.319    0.139    0.390 

Gapped
Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 1
Number of Hits to DB: 287
Number of extensions: 15
Number of successful extensions: 3
Number of sequences better than 1.0e-02: 1
Number of HSP's gapped: 1
Number of HSP's successfully gapped: 1
Length of query: 353
Length of database: 361
Length adjustment: 29
Effective length of query: 324
Effective length of database: 332
Effective search space:   107568
Effective search space used:   107568
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 49 (23.5 bits)

This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.

Links

Downloads

Related tools

About GapMind

Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.

A candidate for a step is "high confidence" if either:

where "other" refers to the best ublast hit to a sequence that is not annotated as performing this step (and is not "ignored").

Otherwise, a candidate is "medium confidence" if either:

Other blast hits with at least 50% coverage are "low confidence."

Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:

GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).

For more information, see:

If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know

by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory